Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…
Sell
44
XHE Quote, Financials, Valuation and Earnings
Last price:
$82.27
Seasonality move
:
3.66%
Day range:
$81.59 - $82.20
52-week range:
$71.25 - $97.10
Dividend yield:
0.04%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3K
Avg. volume:
11.3K
1-year change:
-5.06%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XHE
SPDR S&P Health Care Equipment ETF
|
$81.70 | -- | -- | -- | $0.03 | 0.04% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$62.62 | -- | -- | -- | $0.03 | 0.07% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$78.91 | -- | -- | -- | $0.27 | 1.15% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$78.77 | -- | -- | -- | $0.01 | 0.18% | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
$96.26 | -- | -- | -- | $0.04 | 0.33% | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
$40.12 | -- | -- | -- | $0.15 | 1.64% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | 1.636 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 1.183 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.581 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.543 | -- | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
-- | 1.308 | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | 0.578 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
SPDR S&P Health Care Equipment ETF vs. Competitors
-
Which has Higher Returns XHE or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHESPDR S&P Health Care Equipment ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About XHE or PBE?
SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHESPDR S&P Health Care Equipment ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is XHE or PBE More Risky?
SPDR S&P Health Care Equipment ETF has a beta of 1.069, which suggesting that the stock is 6.861% more volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.840, suggesting its less volatile than the S&P 500 by 15.98%.
-
Which is a Better Dividend Stock XHE or PBE?
SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. Invesco Biotechnology & Genome ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHE or PBE?
SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHESPDR S&P Health Care Equipment ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns XHE or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHESPDR S&P Health Care Equipment ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHE or PJP?
SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHESPDR S&P Health Care Equipment ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is XHE or PJP More Risky?
SPDR S&P Health Care Equipment ETF has a beta of 1.069, which suggesting that the stock is 6.861% more volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.530, suggesting its less volatile than the S&P 500 by 46.992%.
-
Which is a Better Dividend Stock XHE or PJP?
SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. Invesco Pharmaceuticals ETF offers a yield of 1.15% to investors and pays a quarterly dividend of $0.27 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHE or PJP?
SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHESPDR S&P Health Care Equipment ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns XHE or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHESPDR S&P Health Care Equipment ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About XHE or XBI?
SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHESPDR S&P Health Care Equipment ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is XHE or XBI More Risky?
SPDR S&P Health Care Equipment ETF has a beta of 1.069, which suggesting that the stock is 6.861% more volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.396%.
-
Which is a Better Dividend Stock XHE or XBI?
SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. SPDR S&P Biotech ETF offers a yield of 0.18% to investors and pays a quarterly dividend of $0.01 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHE or XBI?
SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHESPDR S&P Health Care Equipment ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns XHE or XHS?
SPDR S&P Health Care Services ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat SPDR S&P Health Care Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHESPDR S&P Health Care Equipment ETF-- -- -- XHSSPDR S&P Health Care Services ETF-- -- -- -
What do Analysts Say About XHE or XHS?
SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than SPDR S&P Health Care Services ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than SPDR S&P Health Care Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHESPDR S&P Health Care Equipment ETF0 0 0 XHSSPDR S&P Health Care Services ETF0 0 0 -
Is XHE or XHS More Risky?
SPDR S&P Health Care Equipment ETF has a beta of 1.069, which suggesting that the stock is 6.861% more volatile than S&P 500. In comparison SPDR S&P Health Care Services ETF has a beta of 1.046, suggesting its more volatile than the S&P 500 by 4.633%.
-
Which is a Better Dividend Stock XHE or XHS?
SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. SPDR S&P Health Care Services ETF offers a yield of 0.33% to investors and pays a quarterly dividend of $0.04 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHE or XHS?
SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Services ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than SPDR S&P Health Care Services ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for SPDR S&P Health Care Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHESPDR S&P Health Care Equipment ETF-- -- -- -- XHSSPDR S&P Health Care Services ETF-- -- -- --
-
Which has Higher Returns XHE or XPH?
SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHESPDR S&P Health Care Equipment ETF-- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHE or XPH?
SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHESPDR S&P Health Care Equipment ETF0 0 0 XPHSPDR S&P Pharmaceuticals ETF0 0 0 -
Is XHE or XPH More Risky?
SPDR S&P Health Care Equipment ETF has a beta of 1.069, which suggesting that the stock is 6.861% more volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.646, suggesting its less volatile than the S&P 500 by 35.443%.
-
Which is a Better Dividend Stock XHE or XPH?
SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.64% to investors and pays a quarterly dividend of $0.15 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHE or XPH?
SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHESPDR S&P Health Care Equipment ETF-- -- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
10
EXOD alert for May 29
Exodus Movement [EXOD] is up 15.88% over the past day.
Buy
80
SBET alert for May 29
SharpLink Gaming [SBET] is up 99.79% over the past day.
Buy
100
BOX alert for May 29
Box [BOX] is down 0.52% over the past day.
